Search Results - "Waselenko, J K"

Rituximab Using A Thrice Weekly Dosing Schedule in B-Cell Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Demonstrates Clinical Activity and Acceptable Toxicity by Byrd, J C, Murphy, T, Howard, R S, Lucas, M S, Goodrich, A, Park, K, Pearson, M, Waselenko, J K, Ling, G, Grever, M R, Grillo-Lopez, A J, Rosenberg, J, Kunkel, L, Flinn, I W

“…Rituximab has been reported to have little activity in small lymphocytic lymphoma (SLL)/chronic lymphocytic leukemia (CLL) and to be associated with…”
Get full text

Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53 by BYRD, J. C, SHINN, C, WASELENKO, J. K, FUCHS, E. J, LEHMAN, T. A, NGUYEN, P. L, FLINN, I. W, DIEHL, L. F, SAUSVILLE, E, GREVER, M. R

“…Flavopiridol has been reported to induce apoptosis in lymphoid cell lines via downregulation of bcl-2. The in vitro activity of flavopiridol against human…”
Get full text

Rituximab Therapy in Hematologic Malignancy Patients With Circulating Blood Tumor Cells: Association With Increased Infusion-Related Side Effects and Rapid Blood Tumor Clearance by BYRD, J. C, WASELENKO, J. K, MANEATIS, T. J, MURPHY, T, WARD, F. T, MONAHAN, B. P, SIPE, M. A, DONEGAN, S, WHITE, C. A

“…Rituximab was recently approved for use in relapsed, low-grade non-Hodgkin's lymphoma; however, few data exist regarding the safety of this agent in patients…”
Get full text

Novel therapies for chronic lymphocytic leukemia in the 21st century by Byrd, J C, Waselenko, J K, Keating, M, Rai, K, Grever, M R

“…Chronic lymphocytic leukemia (CLL) is one of the most common types of leukemia diagnosed in the Western Hemisphere. Introduction of the purine analogs has…”
Get more information

Depsipeptide (FR901228): A Novel Therapeutic Agent With Selective, In Vitro Activity Against Human B-Cell Chronic Lymphocytic Leukemia Cells by Byrd, John C., Shinn, Charlotte, Ravi, Rajani, Willis, Carl R., Waselenko, Jamie K., Flinn, Ian W., Dawson, Nancy A., Grever, Michael R.

“…Therapy of B-cell chronic lymphocytic leukemia (CLL) has been limited by both the nonselectivity of therapeutic agents toward normal residual immune cells and…”
Get full text

Women with thrombophilia: assessing the risks for thrombosis with oral contraceptives or hormone replacement therapy by Waselenko, J K, Nace, M C, Alving, B

“…Women with inherited or acquired thrombophilia are at increased risk for venous thromboembolism (VTE) when they use oral contraceptives (OCs) of either the…”
Get more information

Stem-cell transplantation in chronic lymphocytic leukemia: the time for designing randomized studies has arrived by Waselenko, J K, Flynn, J M, Byrd, J C

“…Stem-cell transplantation in conjunction with myeloablative therapy has evolved as a standard treatment option for patients with several hematologic…”
Get more information

MEDICAL MANAGEMENT OF RADIOLOGICAL CASUALTIES by Goans, Ronald E, Waselenko, Jamie K

“…Victims of radiological terrorism events require prompt diagnosis and treatment of medical and surgical conditions as well as conditions related to radiation…”
Get full text

Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia by Waselenko, J K, Grever, M R, Beer, M, Lucas, M A, Byrd, J C

“…Renewed interest in chronic lymphocytic leukemia (CLL) has led to an unprecedented number of investigators contributing to all aspects of research in this…”
Get more information

Carboxyamido-Triazole (CAI)-a Novel "static" Signal Transduction Inhibitor Induces Apoptosis in Human B-Cell Chronic Lymphocytic Leukemia Cells by Waselenko, Jamie K., Shinn, Charlotte A., Willis, Carl R., Flinn, Ian W., Grever, Michael R., Byrd, John C.

“…Signal transduction is a key mechanism by which both proliferative and apoptotic processes of B-cell chronic lymphocytic leukemia (CLL) cells are mediated…”
Get full text

Gemcitabine demonstrates in vitro activity against human B-cell chronic lymphocytic leukemia by Waselenko, Jamie K, Grever, Michael R, Shinn, Charlotte A, Flinn, Ian W, Byrd, John C

“…B-cell chronic lymphocytic leukemia (CLL) is the most common type of leukemia diagnosed in the Western Hemisphere and remains incurable with currently…”
Get full text

Medical management of the acute Radiation syndrome: Recommendations of the Strategic National Stockpile Radiation Working Group by WASELENKO, Jamie K, MACVITTIE, Thomas J, LOWRY, Patrick, ARMITAGE, James O, DAINIAK, Nicholas, BLAKELY, William F, PESIK, Nicki, WILEY, Albert L, DICKERSON, William E, TSU, Horace, CONFER, Dennis L, COLEMAN, C. Norman, SEED, Thomas

“…Physicians, hospitals, and other health care facilities will assume the responsibility for aiding individuals injured by a terrorist act involving radioactive…”
Get full text

Preservation of nucleic acids for polymerase chain reaction after prolonged storage at room temperature by Tuttle, R M, Waselenko, J K, Yosseffi, P, Weigand, N, Martin, R K

“…A guanidinium isothiocyanate (GITC) lysis solution was evaluated for its efficacy in preserving nucleic acids for subsequent analysis after prolonged storage…”
Get more information

Medical management of patients with multiple organ dysfunction arising from acute radiation syndrome by Jackson, W L, Gallagher, C, Myhand, R C, Waselenko, J K

Get full text

Depsipeptide (FR901228): A Novel Therapeutic Agent With Selective, In Vitro Activity Against Human B-Cell Chronic Lymphocytic Leukemia Cells by Byrd, John C., Shinn, Charlotte, Ravi, Rajani, Willis, Carl R., Waselenko, Jamie K., Flinn, Ian W., Dawson, Nancy A., Grever, Michael R.

“…Therapy of B-cell chronic lymphocytic leukemia (CLL) has been limited by both the nonselectivity of therapeutic agents toward normal residual immune cells and…”
Get full text

Management of progressive metastatic prostate cancer by Waselenko, J K, Dawson, N A

“…Metastatic prostate cancer is a growing health problem and is the second leading cause of cancer death in men. While the response of patients with metastatic…”
Get more information

Thrombotic microangiopathy (TMA) and stroke due to human herpesvirus‐6 (HHV‐6) reactivation in an adult receiving high‐dose melphalan with autologous peripheral stem cell transplantation by Belford, Amy, Myles, Otha, Magill, Alan, Wang, James, Myhand, Rick C., Waselenko, Jamie K.

“…We report an adult autologous stem cell transplant (ASCT) patient who developed transplant‐associated thrombotic microangiopathy (TMA) due to human…”
Get full text

Acute Radiation Injury: Contingency Planning for Triage, Supportive Care, and Transplantation by Weisdorf, Daniel, Chao, Nelson, Waselenko, Jamie K., Dainiak, Nicholas, Armitage, James O., McNiece, Ian, Confer, Dennis

“…Evaluation and management of victims of exposure to myelosuppressive radiation in a military, terrorist, or accidental event is challenging. The hematopoietic…”
Get full text

Post-transplant interleukin-2 in patients with low-grade lymphoid neoplasms previously treated with fludarabine is limited by hematologic toxicity by WASELENKO, Jamie K, BURROWS, Ann, NELSON, Douglas A, LUCAS, Margaret, EKSTRAND, John, EDENFIELD, William Jeffrey, MYHAND, Rick C

“…Given the favorable immunologic effects of IL-2 post transplant, we conducted a feasibility study examining rIL-2 1.0x106 IU/m2/day (SQ) beginning on D+14…”
Get full text